Speciality diagnostics company Orgentec Diagnostika has announced that its board of directors has appointed Gary Winer to President and CEO, effective immediately.
Gary brings 20 years’ experience to the role, including senior leadership roles on an international scale with a number of diagnostic and pharmaceutical companies. In addition, he has led successful launches and the growth of successful product lines in the US, Latin America, Asia and Japan. It is hoped he will leverage his extensive global healthcare experience to further Orgentec’s growth.
"The combination of Gary's diagnostic and global experience is the ideal match for Orgentec. We're thrilled to gain the benefit of his years of industry expertise and insight as we build and enhance Orgentec's global reach, sizeable installed instrument base, and unique menu of diagnostic tests to support healthcare providers around the world with identifying rare conditions and diseases," said Scott Garrett, Chairman of Orgentec.
Gary commented on his appointment: "I'm delighted to join Orgentec at this important point in the company's evolution to becoming a world-class specialty diagnostics provider. I'd like to thank Water Street and the board for their confidence in me to build upon the successful foundation established by my predecessor, Jim Widergren. I look forward to working with the outstanding team of professionals across the company to continue to expand our product offerings, particularly for our Alegria product line with its proprietary autoimmune and infectious disease testing menu."